Cover Image
市場調查報告書

中國的臨床化學市場預測

China Clinical Chemistry Market Outlook to 2021

出版商 GlobalData 商品編碼 346054
出版日期 內容資訊 英文 43 Pages
訂單完成後即時交付
價格
Back to Top
中國的臨床化學市場預測 China Clinical Chemistry Market Outlook to 2021
出版日期: 2015年08月14日 內容資訊: 英文 43 Pages
簡介

本報告提供中國的臨床化學市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 中國的臨床化學市場

  • 收益實際成果
  • 收益預測
    • 各市場區隔
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 中國的主要企業概要:臨床化學市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthcare
    • Danaher Corporation
    • Bio-Rad Laboratories, Inc.
    • Mindray Medical International Limited
    • Abbott Laboratories
    • Ortho-Clinical Diagnostics Inc.
    • Sysmex Corporation

第5章 臨床化學市場開發中產品

第6章 財務交易形勢

  • 收購
  • 股票上市
  • 夥伴關係

第7章 最近的發展

  • 公佈財報

第8章 附錄

圖表

目錄
Product Code: GDMECC1243DB

GlobalData's new report, "China Clinical Chemistry Market Outlook to 2021", provides key market data on the China Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Clinical Chemistry market.
  • Global corporate-level profiles of key companies operating within the China Clinical Chemistry market.
  • Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Clinical Chemistry Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Clinical Chemistry Market, China

  • 3.1. Clinical Chemistry Market, China, Revenue ($m), 2007-2014
  • 3.2. Clinical Chemistry Market, China, Revenue ($m), 2014-2021
    • 3.2.1. Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Urine Analysis Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Urine Analysis Market, China, Revenue ($m), by Segment, 2014-2021
  • 3.3. Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.4. Clinical Chemistry Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Clinical Chemistry Market

  • 4.1. F. Hoffmann-La Roche Ltd.
    • 4.1.1. Company Overview
  • 4.2. Siemens Healthcare
    • 4.2.1. Company Overview
  • 4.3. Danaher Corporation
    • 4.3.1. Company Overview
  • 4.4. Bio-Rad Laboratories, Inc.
    • 4.4.1. Company Overview
  • 4.5. Mindray Medical International Limited
    • 4.5.1. Company Overview
  • 4.6. Abbott Laboratories
    • 4.6.1. Company Overview
  • 4.7. Ortho-Clinical Diagnostics Inc.
    • 4.7.1. Company Overview
  • 4.8. Sysmex Corporation
    • 4.8.1. Company Overview

5. Clinical Chemistry Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million
  • 6.2. Equity Offerings
    • 6.2.1. Beijing Strong Biotech Prices IPO for USD57 Million
  • 6.3. Partnerships
    • 6.3.1. NoemaLife Enters into Distribution Agreement with Horiba Medical

7. Recent Developments

  • 7.1. Financial Announcements
    • 7.1.1. Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Company Share Analysis
    • 8.1.5. Distribution Share Analysis
  • 8.2. GlobalData Consulting
  • 8.3. Contact Us
  • 8.4. Disclaimer

List of Tables

  • Table 1: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 10: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 11: Clinical Chemistry Market Pipeline Products
  • Table 12: Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million
  • Table 13: Beijing Strong Biotech Prices IPO for USD57 Million
  • Table 14: NoemaLife Enters into Distribution Agreement with Horiba Medical

List of Figures

  • Figure 1: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Clinical Chemistry Market, China, Company Share (%) 2014
Back to Top